Bill > HF978

This bill establishes a comprehensive regulatory framework for the production, testing, and medical administration of psilocybin in Iowa, creating a detailed system for licensing, registration, and oversight of psilocybin-related activities. The bill creates a new chapter of law defining key terms and establishing a Psilocybin Production Establishment Licensing Board within the Department of Health and Human Services to manage the program. Medical professionals will need to obtain special registration to recommend or administer psilocybin, undergo specific continuing education, and follow strict protocols, including obtaining patient consent, maintaining detailed records, and ensuring patient safety during administration sessions. Psilocybin production facilities will be subject to rigorous licensing requirements, including inventory tracking, security measures, and testing protocols to ensure product safety. The bill allows psilocybin use only for medical purposes, with patients needing to be at least 21 years old and having a recommendation from a qualified medical provider. Notably, the bill provides protections for employees and patients, preventing discrimination based on medical psilocybin use, and includes provisions to protect medical providers from federal legal repercussions. The program is set to begin accepting applications on July 1, 2026, with the department required to submit annual reports on the program's implementation and effectiveness, and conduct a broader study on psychedelic compounds in medical treatment by January 1, 2026.

Budget and Finance

Ways and Means (H)

https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=HF978